Regulatory T Cell Suppressive Activity Predicts Disease Relapse During Disease-Modifying Anti-rheumatic Drug Dose Reduction in Rheumatoid Arthritis: A Prospective Cohort Study
© Copyright © 2020 Kanjana, Chevaisrakul, Matangkasombut, Paisooksantivatana and Lumjiaktase. When the dose of conventional disease-modifying anti-rheumatic drugs (cDMARDs) is tapered in rheumatoid arthritis (RA) patients who achieve sustained remission, biomarkers for predicting disease relapse may...
Saved in:
Main Authors: | Korawit Kanjana, Parawee Chevaisrakul, Ponpan Matangkasombut, Karan Paisooksantivatana, Putthapoom Lumjiaktase |
---|---|
Other Authors: | Faculty of Medicine, Ramathibodi Hospital, Mahidol University |
Format: | Article |
Published: |
2020
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/53760 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Efficient short-term expansion of human peripheral blood regulatory T cells for co-culture suppression assay
by: Korawit Kanjana, et al.
Published: (2020) -
Drug survival and reasons for discontinuation of the first biological disease modifying antirheumatic drugs in Thai patients with rheumatoid arthritis: Analysis from the Thai Rheumatic Disease Prior Authorization registry
by: Pongthorn Narongroeknawin, et al.
Published: (2018) -
Drug survival and reasons for discontinuation of the first biological disease modifying antirheumatic drugs in Thai patients with rheumatoid arthritis: Analysis from the Thai Rheumatic Disease Prior Authorization registry
by: Pongthorn Narongroeknawin, et al.
Published: (2019) -
2016 updated Thai Rheumatism Association Recommendations for the use of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis
by: Worawit Louthrenoo, et al.
Published: (2018) -
2016 updated Thai Rheumatism Association Recommendations for the use of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis
by: Worawit Louthrenoo, et al.
Published: (2018)